Skip to main content

Advertisement

Table 2 Paralemmin-1 protein expression in reduction mammoplasty and breast cancer cases

From: Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers

  RM DCIS IDC DCIS & IDC
     ER PR HER2
     Pos Neg Pos Neg Pos Neg
Weak 29 (73) 7 (23) 20 (31) 21 (26) 8 (57) 16 (23) 12 (48) 7 (29) 20 (30)
Strong 11 (27) 24 (77) 45 (65) 60 (74) 6 (43) 54 (77) 13 (52) 17 (71) 47 (70)
  1. Number and (percent) of cases in each category that were scored either weak or strong for paralemmin-1 protein expression. RM: reduction mammoplasty; DCIS: ductal carcinoma in situ; IDC: invasive ductal carcinoma; ER: estrogen receptor; PR: progesterone receptor; HER2: human epidermal growth factor receptor 2.